Form 8-K - Current report:
SEC Accession No. 0001016169-11-000017
Filing Date
2011-05-23
Accepted
2011-05-23 16:41:46
Documents
2
Period of Report
2011-05-17
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8k.htm 8-K 70125
2 exhibit10.htm EX-10.1 75241
  Complete submission text file 0001016169-11-000017.txt   146964
Mailing Address 250 PHILLIPS BLVD SUITE 290 EWING NJ 08618
Business Address 250 PHILLIPS BLVD SUITE 290 EWING NJ 08618 609-359-3020
ANTARES PHARMA, INC. (Filer) CIK: 0001016169 (see all company filings)

IRS No.: 411350192 | State of Incorp.: DE | Fiscal Year End: 1208
Type: 8-K | Act: 34 | File No.: 001-32302 | Film No.: 11865457
SIC: 3841 Surgical & Medical Instruments & Apparatus